Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023)

Historic Interest Coverage Ratio for Contineum Therapeutics (CTNM) over the last 1 years, with Q2 2023 value amounting to 335.66.

  • Contineum Therapeutics' Interest Coverage Ratio changed N/A to 335.66 in Q2 2023 from the same period last year, while for Mar 2024 it was 97.09, marking a year-over-year change of. This contributed to the annual value of 77.29 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Contineum Therapeutics reported Interest Coverage Ratio of 335.66 as of Q2 2023.
  • Over the past 5 years, Contineum Therapeutics' Interest Coverage Ratio peaked at 335.66 during Q2 2023, and registered a low of 55.6 during Q1 2023.